CPT code 42804 represents a diagnostic procedure in which a clinician obtains a biopsy from a visible lesion of the nasopharynx. This procedure is important nationally because it supports definitive tissue diagnosis for conditions ranging from benign inflammatory lesions to malignancy, guiding subsequent treatment decisions and care pathways. The code applies across outpatient and clinic settings where ENT specialists and trained providers perform nasopharyngeal visualization and sampling. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context and typical service setting for CPT code 42804, an overview of common payer coverage considerations, and what to expect in terms of billing practice and coding relationships. The publication summarizes available benchmarks and common modifier use where documented, highlights relevant coding crosswalks when applicable, and outlines clinical factors that commonly justify the procedure. Data not available in the input is noted where gaps exist.